Do age, gender, development, and other characteristics in children with autism affect their likelihood of gastrointestinal symptoms? Researchers report their findings.
Triple therapy has been the gold standard for treatment of H pylori infection for several years. New research casts light on whether that standard should change.
The many different classes of medications available for treating inflammatory bowel disease give gastroenterologists more options than ever before—and also more challenges in determining how to balance...
The treatment of inflammatory bowel disease has changed dramatically since the introduction of biologics and small molecule therapeutics. But does that mean older therapies no longer have any role? David...
Some patients with IBD require surgery to improve symptoms and quality of life. Joel Goldberg, MD, explained how to help patients prepare for surgery and achieve optimum recovery at the Advances in...
Preliminary results of the PROMISE trial highlight the relationship between nonalcoholic fatty liver disease and cardiovascular disease, which has been debated previously.
For her session at the 21st Annual Harvard Nutrition and Obesity Symposium on NAFLD, Kathleen Corey, MD, MPH, MMSc, highlighted her research on the connection between NAFLD and cardiovascular disease.
In a study presented at the 21st Annual Harvard Nutrition and Obesity Symposium, Kathleen E. Corey, MD, spoke about the risk factors for cardiovascular disease and MACE among patients with NAFLD.
Researchers sought to better understand the optimal timing of administering colonoscopy to patients admitted to the hospital with acute lower gastrointestinal bleeding.
